MRSA pneumonia mortality correlated with vancomycin MIC

In this retrospective cohort of patients with MRSA pneumonia, overall 1 month mortality was 32%, with mortality increasing with increasing vancomycin MIC. The authors recommend alternative agents (eg linezolid) in patients with MIC>1 (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment